QSS
IMVT icon

Quantitative Systematic Strategies’s Immunovant IMVT Stock Holding History

Quantitative Systematic Strategies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,915
Closed -$319K – 683
2020
Q4 		$319K Sell
6,915
-5,795
-46% -$268K 0.05% 471
2020
Q3 		$447K Sell
12,710
-4,360
-26% -$131K 0.08% 350
2020
Q2 		$416K Buy
17,070
+1,561
+10% +$33.5K 0.08% 347
2020
Q1 		$241K Buy
+15,509
New +$233K 0.2% 182

Other funds holding IMVT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Quantitative Systematic Strategies's IMVT Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Immunovant (IMVT) in Q1 2021, closing a stake of 6,915 shares — an estimated $319K sold.

Quantitative Systematic Strategies first reported a position in IMVT in Q1 2020 and held it in 4 quarters. The position peaked at $447K in Q3 2020. 120 funds tracked by Wall St. Rank hold IMVT as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Immunovant position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,915 Immunovant shares in Q1 2021, an estimated $319K.
  • Quantitative Systematic Strategies first reported a position in Immunovant in Q1 2020 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Immunovant position peaked at $447K in Q3 2020.
  • 120 funds tracked by Wall St. Rank held Immunovant as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.